NRx Pharmaceuticals outlines rapid clinic expansion and targets 6 or more locations by year-end 2025 amid new depression treatment advances
Source: SeekingAlpha
2025-11-17 11:58:13 ET
More on NRx Pharmaceuticals
- NRx Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call Transcript
- NRx Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call Transcript
- NRx Pharmaceuticals reports Q3 results
- NRx Pharmaceuticals gets FDA approval for suitability petition of Ketafree
- Seeking Alpha’s Quant Rating on NRx Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
NRx Pharmaceuticals outlines rapid clinic expansion and targets 6 or more locations by year-end 2025 amid new depression treatment advances
NRX Pharmaceuticals Inc. Warrant
NASDAQ: NRXPW
NRXPW Trading
3.32% G/L:
$0.028 Last:
76,526 Volume:
$0.027 Open:
NRXPW Latest News
NRXPW Stock Data
$51,919,863
21,256,498
N/A
13
N/A
Biotechnology & Life Sciences
Healthcare
US
Wilmington
